Capstone Therapeutics Corp.

Industry

  • Biotechnology
    • Liposomes
    • Large Molecule
  • Pharmaceuticals

Other Names/Subsidiaries

  • OrthoLogic Corp.
See more in Biomedtracker

Latest on Capstone Therapeutics Corp.

Scrip

Deal Watch: Allergan, Celgene, AstraZeneca Among Biopharmas Advancing Existing Partnerships

 
• By Joseph Haas and Lucie Ellis-Taitt

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Scrip

Venture Funding Deals: New Cash For Delinia, Peloton, Fortis & Others

 
• By Deanna Kamienski, Beth Allan, Maureen Riordan, and Steven Muntner

Advantagene Closes $14.2m Series A Round Immuno-oncology firm Advantagene Inc. raised $14.2m through the sale of its Series A convertible preferred shares to undisclosed investors. National Securi

Scrip

Venture Funding Deals, January 2016

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS AltheaDx Inc. AltheaDx 's Series C brings in $30mm AltheaDx Inc. (oncology R&D services and personalized medicine focused on cardio, neuro, and blood disorders) brought in

Scrip

Start-Up Quarterly Statistics, Q3 2012

 
• By Deanna Kamienski

Financings In the third quarter of 2012, start-up companies raised a total of $682 million across all industries, up roughly 19% from the previous quarter. ( See Exhibit 1. ) Of that money, $439.5 mil